P3.12.03 Retrospective Analysis of Age, EGFR Mutation Type, and TP53 Co-Mutation on Survival Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer
Back to course
Asset Subtitle
Eric Singhi
Meta Tag
Speaker Eric Singhi
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Powered By